Annual Revenue
$90.24 M
-$22.48 M-19.94%
31 December 2023
Summary:
REGENXBIO annual revenue is currently $90.24 million, with the most recent change of -$22.48 million (-19.94%) on 31 December 2023. During the last 3 years, it has fallen by -$64.33 million (-41.62%). RGNX annual revenue is now -80.81% below its all-time high of $470.35 million, reached on 31 December 2021.RGNX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$24.20 M
+$1.90 M+8.53%
30 September 2024
Summary:
REGENXBIO quarterly revenue is currently $24.20 million, with the most recent change of +$1.90 million (+8.53%) on 30 September 2024. Over the past year, it has dropped by -$4.72 million (-16.31%). RGNX quarterly revenue is now -93.93% below its all-time high of $398.65 million, reached on 31 December 2021.RGNX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$84.33 M
-$4.72 M-5.30%
30 September 2024
Summary:
REGENXBIO TTM revenue is currently $84.33 million, with the most recent change of -$4.72 million (-5.30%) on 30 September 2024. Over the past year, it has dropped by -$15.05 million (-15.14%). RGNX TTM revenue is now -82.59% below its all-time high of $484.30 million, reached on 30 June 2022.RGNX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGNX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.9% | -16.3% | -15.1% |
| 3 y3 years | -41.6% | -21.4% | -9.5% |
| 5 y5 years | -58.7% | +64.6% | +31.3% |
RGNX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -80.8% | at low | -93.9% | +54.9% | -82.6% | at low |
| 5 y | 5 years | -80.8% | +156.1% | -93.9% | +105.6% | -82.6% | +139.3% |
| alltime | all time | -80.8% | +1866.5% | -93.9% | >+9999.0% | -82.6% | >+9999.0% |
REGENXBIO Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $24.20 M(+8.5%) | $84.33 M(-5.3%) |
| June 2024 | - | $22.30 M(+42.7%) | $89.04 M(+2.7%) |
| Mar 2024 | - | $15.62 M(-29.7%) | $86.73 M(-3.9%) |
| Dec 2023 | $90.24 M(-19.9%) | $22.21 M(-23.2%) | $90.24 M(-9.2%) |
| Sept 2023 | - | $28.91 M(+44.7%) | $99.37 M(+2.5%) |
| June 2023 | - | $19.98 M(+4.4%) | $96.97 M(-11.6%) |
| Mar 2023 | - | $19.14 M(-38.9%) | $109.64 M(-2.7%) |
| Dec 2022 | $112.72 M(-76.0%) | $31.34 M(+18.2%) | $112.72 M(-76.5%) |
| Sept 2022 | - | $26.51 M(-18.8%) | $480.03 M(-0.9%) |
| June 2022 | - | $32.65 M(+46.9%) | $484.30 M(+2.2%) |
| Mar 2022 | - | $22.22 M(-94.4%) | $473.68 M(+0.7%) |
| Dec 2021 | $470.35 M(+204.3%) | $398.65 M(+1195.5%) | $470.35 M(+405.0%) |
| Sept 2021 | - | $30.77 M(+39.7%) | $93.14 M(-42.2%) |
| June 2021 | - | $22.04 M(+16.7%) | $161.28 M(+3.5%) |
| Mar 2021 | - | $18.88 M(-11.9%) | $155.81 M(+0.8%) |
| Dec 2020 | $154.57 M(+338.7%) | $21.45 M(-78.3%) | $154.57 M(+6.7%) |
| Sept 2020 | - | $98.91 M(+497.1%) | $144.89 M(+138.8%) |
| June 2020 | - | $16.57 M(-6.1%) | $60.68 M(+16.7%) |
| Mar 2020 | - | $17.64 M(+49.9%) | $51.99 M(+47.6%) |
| Dec 2019 | $35.23 M | $11.77 M(-19.9%) | $35.23 M(-45.2%) |
| Sept 2019 | - | $14.70 M(+86.5%) | $64.24 M(+17.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $7.88 M(+791.5%) | $54.85 M(-37.0%) |
| Mar 2019 | - | $884.00 K(-97.8%) | $87.00 M(-60.2%) |
| Dec 2018 | $218.50 M(+2002.4%) | $40.78 M(+668.5%) | $218.50 M(+21.5%) |
| Sept 2018 | - | $5.31 M(-86.7%) | $179.77 M(+2.3%) |
| June 2018 | - | $40.03 M(-69.8%) | $175.80 M(+23.5%) |
| Mar 2018 | - | $132.39 M(+6389.8%) | $142.33 M(+1269.5%) |
| Dec 2017 | $10.39 M(+126.5%) | $2.04 M(+52.7%) | $10.39 M(+3.4%) |
| Sept 2017 | - | $1.34 M(-79.6%) | $10.05 M(+13.7%) |
| June 2017 | - | $6.56 M(+1342.2%) | $8.84 M(+90.0%) |
| Mar 2017 | - | $455.00 K(-73.2%) | $4.65 M(+1.4%) |
| Dec 2016 | $4.59 M(-39.5%) | $1.70 M(+1256.8%) | $4.59 M(-37.5%) |
| Sept 2016 | - | $125.00 K(-94.7%) | $7.34 M(-12.1%) |
| June 2016 | - | $2.38 M(+504.3%) | $8.36 M(+13.8%) |
| Mar 2016 | - | $393.00 K(-91.2%) | $7.34 M(-3.3%) |
| Dec 2015 | $7.59 M(+24.0%) | $4.45 M(+290.2%) | $7.59 M(+76.8%) |
| Sept 2015 | - | $1.14 M(-16.4%) | $4.29 M(+18.1%) |
| June 2015 | - | $1.36 M(+111.6%) | $3.64 M(+59.9%) |
| Mar 2015 | - | $644.00 K(-43.9%) | $2.27 M(+39.5%) |
| Dec 2014 | $6.12 M(+0.5%) | $1.15 M(+137.7%) | $1.63 M(+237.7%) |
| Sept 2014 | - | $483.00 K | $483.00 K |
| Dec 2013 | $6.09 M | - | - |
FAQ
- What is REGENXBIO annual revenue?
- What is the all time high annual revenue for REGENXBIO?
- What is REGENXBIO annual revenue year-on-year change?
- What is REGENXBIO quarterly revenue?
- What is the all time high quarterly revenue for REGENXBIO?
- What is REGENXBIO quarterly revenue year-on-year change?
- What is REGENXBIO TTM revenue?
- What is the all time high TTM revenue for REGENXBIO?
- What is REGENXBIO TTM revenue year-on-year change?
What is REGENXBIO annual revenue?
The current annual revenue of RGNX is $90.24 M
What is the all time high annual revenue for REGENXBIO?
REGENXBIO all-time high annual revenue is $470.35 M
What is REGENXBIO annual revenue year-on-year change?
Over the past year, RGNX annual revenue has changed by -$22.48 M (-19.94%)
What is REGENXBIO quarterly revenue?
The current quarterly revenue of RGNX is $24.20 M
What is the all time high quarterly revenue for REGENXBIO?
REGENXBIO all-time high quarterly revenue is $398.65 M
What is REGENXBIO quarterly revenue year-on-year change?
Over the past year, RGNX quarterly revenue has changed by -$4.72 M (-16.31%)
What is REGENXBIO TTM revenue?
The current TTM revenue of RGNX is $84.33 M
What is the all time high TTM revenue for REGENXBIO?
REGENXBIO all-time high TTM revenue is $484.30 M
What is REGENXBIO TTM revenue year-on-year change?
Over the past year, RGNX TTM revenue has changed by -$15.05 M (-15.14%)